Skip to content
thestock.space

Sahajanand Medical Technologies (SMT) had a P/E of 77.3× on 6 Nov 2026, above the industry P/E of 34.9×. It earns ROCE of 13% and ROE of 11%. Debt is 0.49× equity. It is a small-cap company with a market cap of ₹5,346 Cr, ranked 2nd of 9 Medical Devices companies by market cap; the shares rose 39% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹517.00
Day high
₹531.95
Day low
₹485.20
Prev. close
₹487.75
Volume
35.4 L

Health check

3 fair · 2 to check
  • ReturnsIn line

    +39.3% over a year, better than 4 of 7 peers.

  • Price tagPricier

    P/E 77.3 vs industry 34.9.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityAverage

    ROCE 13.3% vs peer median 14.5%.

  • Balance sheetFair

    Debt 0.49× equity, interest covered 4.3×, Piotroski 6 of 9.

  • Red flags1 to check

    P/E of 77.3 against an industry P/E of 34.9.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Devices

8 listed peers. Screen the industry

Small cap

₹5,346 Cr, #2 of 9 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹1,211 Cr · profit ₹65 Cr
Market cap
₹5,346 Cr
Small cap
P/E
77.3
Industry 34.9
Price to book
7.42
Peers 2.85
Dividend yield
0.00%
ROE
10.7%
Peers 11.7%
ROCE
13.3%
Peers 14.5%
Debt to equity
0.49
Debt ₹354 Cr
EPS (TTM)
₹6.80
Face value ₹1
OPM (TTM)
8.4%
Net margin 5.4%
Sales growth
n/a
Year-ago quarter not reported
Profit growth
n/a
Year-ago quarter not reported
Price to sales
4.42
EV/EBITDA 32.1

Strengths and risks

Strengths

  • Positive operating cash flow in each of the last 3 years.

Risks to check

  • P/E of 77.3 against an industry P/E of 34.9.

Derived automatically from reported figures. Not a recommendation.

About Sahajanand Medical Technologies

Sahajanand Medical Technologies Limited engages in the manufacture and distribution of Class III and Class C/D medical devices in India, Europe, rest of the Asia Pacific, Latin America, and the Middle East and Africa. The company provides vascular intervention products coronary stents and balloons used to diagnose or treat diseases of the blood vessels; structural heart products comprising trans-catheter aortic valves and occluders used to treat defects…

Headquarters
Surat
Employees
1,605
Sector
Healthcare
ISIN
INE356Y01018
Website
smtpl.com

Price range

52 weeks

₹346.65₹565.75

Today

₹485.20₹531.95
Avg volume (3M)
50.2 L
1-year return
plus 39.3%
From 52-week high
minus 7.0%

Peers · Medical Devices

Compare with peersScreen the whole industry
Company
MOLBIOMolbio Diagnostics1,339.30minus 4.57%15,43492.612.9116.5%15.6%20.4%63.7%–0.00%plus 28.6%
SMTSahajanand Medical Technologies525.95plus 7.83%5,34677.37.4213.3%10.7%8.4%––0.00%plus 39.3%
FISCHERFischer Medical Ventures24.30minus 2.88%1,69810.44.0812.5%8.9%12.5%1097.3%–0.21%minus 73.4%
HSILHemant Surgical Industries628.65minus 0.21%91442.15.9519.5%18.1%10.0%28.4%33.5%0.00%plus 117.2%
UNIVPHOTOUniversus Photo Imagings480.00minus 1.49%525–0.65−9.5%−9.5%5.4%−24.3%–0.00%plus 74.8%
NURECANureca302.30minus 0.30%30261.41.53–2.5%8.3%9.7%–0.00%plus 17.4%
EARKARTEarkart111.00minus 5.13%15327.82.3712.1%11.7%15.3%23.2%55.5%0.00%minus 48.5%
CHOKSIChoksi Asia210.35minus 0.71%12023.12.8518.4%13.5%14.5%309.2%–0.00%plus 99.0%
Median of 7 peers–−1.49%52534.92.8514.5%11.7%12.5%28.4%44.5%0.00%28.6%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 26
352
303
48.6
13.8%
2.7
6.5
20.4
24.3
37.9%
15.1
1.48

Profit & loss

Yearly, ₹ crore
ROE
10.7%
Net profitSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
9021,0251,211
–+13.7%+18.1%
7928971,040
110128171
12.2%12.5%14.1%
711.18.2
19.420.724.4
64.562.574.2
–−15–
33.140.880.3
122.2%38.4%14.0%
−7.425.269.1
-0.722.47–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
9.79.89.8
530556686
201254306
230275275
9711,0951,276
220217283
13.45.77.5
20.523.437.5
83.9109137
632740811
9711,0951,276

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
41.173.5105
−42.5−48.9−130
13.15.8−12
11.830.4−36.9
−42.3−49−98
−1.224.57.2

Shareholding pattern

Source: NSE filings
36.2%
promoters
  • Promoters36.20%
  • Public60.35%
  • Employee trusts3.46%
  • As of 22 Oct 2026
QuarterSplitPromotersPublicPromoter change
22 Oct 202636.20%60.35%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you